title: Recombinant human thyrotropin use resulting in ovarian hyperstimulation: an unusual side effect.
abstract: A 43-year-old female was administered recombinant human thyrotropin-α (Thyrogen®; Genzyme Corp., Cambridge, Mass., USA) before a fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) scan as part of an evaluation of thyroid cancer recurrence. She was administered two doses of Thyrogen only 4 weeks before for stimulated thyroglobulin measurement. The PET/CT scan demonstrated enlarged ovaries which on subsequent conservative follow-up resolved. This transient hyperstimulated state of the ovaries was presumed to be related to Thyrogen injections received twice within a space of a month. Thyrogen is being increasingly used for raising the level of thyroid-stimulating hormone (TSH), besides thyroid hormone withdrawal for suspected recurrence of differentiated thyroid carcinoma. Ovarian hyperstimulation has been reported as an iatrogenic complication for in vitro fertilization with the presence of human chorionic gonadotropin being invariably associated. Transient gestational thyrotoxicosis has been reported to be related to promiscuous activation of the thyrotropin receptor by chorionic gonadotropin. In our case it is possible that due to the promiscuous stimulation, thyrotropin caused a follicle-stimulating hormone (FSH)-like action resulting in ovarian hyperstimulation. The reason behind this could be the shared sequence identity of the hormone-binding domains of TSH and FSH receptors, or some mutation in the FSH receptor. In conclusion, our case highlights a potential side effect of administering Thyrogen in females of the reproductive age group.
authors.affiliation: Nuclear Medicine Division, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Va., USA.
authors.forename: Tanvir
authors.initials: T
authors.lastname: Rizvi
authors.affiliation: Nuclear Medicine Division, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Va., USA.
authors.forename: Patrice K
authors.initials: PK
authors.lastname: Rehm
keywords: Ovarian hyperstimulation; Positron emission tomography/computed tomography scan; Recombinant human thyrotropin
references.citation: Hum Reprod. 1998 Aug;13(8):2082-7
references.pmid: 9756273
references.citation: DNA. 1988 Dec;7(10):691-9
references.pmid: 3234176
references.citation: Vitam Horm. 2002;64:249-322
references.pmid: 11898394
references.citation: Mol Endocrinol. 1988 Jan;2(1):32-9
references.pmid: 3398841
references.citation: Hum Reprod. 1997 Jun;12(6):1129-37
references.pmid: 9221989
references.citation: Obstet Gynecol Surv. 2001 Dec;56(12):775-82
references.pmid: 11753180
references.citation: J Clin Endocrinol Metab. 1994 Jul;79(1):98-105
references.pmid: 8027262
references.citation: Endocr Rev. 2002 Apr;23(2):141-74
references.pmid: 11943741
references.citation: Cancer. 1998 Sep 1;83(5):1012-21
references.pmid: 9731906
references.citation: Endocr Rev. 1998 Dec;19(6):673-716
references.pmid: 9861544
references.citation: N Engl J Med. 2003 Aug 21;349(8):760-6
references.pmid: 12930928
references.citation: Eur J Endocrinol. 2010 Aug;163(2):177-83
references.pmid: 20484385
references.citation: J Clin Endocrinol Metab. 2003 May;88(5):1933-8
references.pmid: 12727936
references.citation: J Biol Chem. 1988 Sep 5;263(25):12538-42
references.pmid: 2457586
references.citation: J Clin Endocrinol Metab. 2006 Feb;91(2):555-62
references.pmid: 16278261
references.citation: Thyroid. 2008 Jul;18(7):687-94
references.pmid: 18630995
references.citation: Trends Biochem Sci. 2004 Mar;29(3):119-26
references.pmid: 15003269
references.citation: Hum Reprod Update. 2002 Nov-Dec;8(6):559-77
references.pmid: 12498425
references.citation: Thyroid. 2009 Nov;19(11):1167-214
references.pmid: 19860577
references.citation: Eur J Nucl Med. 1999 Dec;26(12):1547-52
references.pmid: 10638405
references.citation: Annu Rev Physiol. 1998;60:461-96
references.pmid: 9558473
references.citation: N Engl J Med. 1998 Dec 17;339(25):1823-6
references.pmid: 9854118
references.citation: Obstet Gynecol Surv. 1989 Jun;44(6):430-40
references.pmid: 2660037
references.citation: J Nucl Med. 2001 Oct;42(10):1464-9
references.pmid: 11585858
references.citation: Endocr Rev. 1997 Jun;18(3):404-33
references.pmid: 9183570
references.citation: Arch Intern Med. 1996 Oct 28;156(19):2165-72
references.pmid: 8885814
references.citation: Arch Pathol Lab Med. 1989 Aug;113(8):921-5
references.pmid: 2667498